How I treat statin-associated side effects in an outpatient setting
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
How I treat statin-associated side effects in an outpatient setting
Authors
Keywords
-
Journal
Future Cardiology
Volume 17, Issue 7, Pages 1249-1260
Publisher
Future Medicine Ltd
Online
2021-01-20
DOI
10.2217/fca-2020-0153
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Efficacy and safety of bempedoic acid for prevention of cardiovascular events and diabetes: a systematic review and meta-analysis
- (2020) Xing Wang et al. Cardiovascular Diabetology
- PCSK9 Inhibitors and Ezetimibe Monotherapy in Patients Not Receiving Statins: A Meta-Analysis of Randomized Trials
- (2020) Benjamin Benhuri et al. Current Vascular Pharmacology
- Intensity of statin treatment after acute coronary syndrome, residual risk, and its modification by alirocumab: insights from the ODYSSEY OUTCOMES trial
- (2020) Rafael Diaz et al. European Journal of Preventive Cardiology
- Association of Bempedoic Acid Administration With Atherogenic Lipid Levels in Phase 3 Randomized Clinical Trials of Patients With Hypercholesterolemia
- (2020) Maciej Banach et al. JAMA Cardiology
- Pharmacogenetics of Statin-Induced Myotoxicity
- (2020) Ping Siu Kee et al. Frontiers in Genetics
- Statin Safety and Associated Adverse Events: A Scientific Statement From the American Heart Association
- (2019) Connie B. Newman et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Comparison of statins for secondary prevention in patients with ischemic stroke or transient ischemic attack: a systematic review and network meta-analysis
- (2019) Irene Tramacere et al. BMC Medicine
- Ezetimibe Lipid-Lowering Trial on Prevention of Atherosclerotic Cardiovascular Disease in 75 or Older (EWTOPIA 75)
- (2019) Yasuyoshi Ouchi et al. CIRCULATION
- Efficacy and safety of bempedoic acid added to ezetimibe in statin-intolerant patients with hypercholesterolemia: A randomized, placebo-controlled study
- (2018) Christie M. Ballantyne et al. ATHEROSCLEROSIS
- Statin-Associated Muscle Disease: Advances in Diagnosis and Management
- (2018) Beth A. Taylor et al. Neurotherapeutics
- Statin Intolerance and Risk of Coronary Heart Events and All-Cause Mortality Following Myocardial Infarction
- (2017) Maria-Corina Serban et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Global, Regional, and National Burden of Cardiovascular Diseases for 10 Causes, 1990 to 2015
- (2017) Gregory A. Roth et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease
- (2017) Marc S. Sabatine et al. NEW ENGLAND JOURNAL OF MEDICINE
- Diagnosis, Prevention, and Management of Statin Adverse Effects and Intolerance: Canadian Consensus Working Group Update (2016)
- (2016) G.B. John Mancini et al. CANADIAN JOURNAL OF CARDIOLOGY
- Laboratory Medicine in the Clinical Decision Support for Treatment of Hypercholesterolemia
- (2016) Gualberto Ruaño et al. CLINICS IN LABORATORY MEDICINE
- Statins for Prevention of Cardiovascular Disease in Adults
- (2016) Roger Chou et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Efficacy and Tolerability of Evolocumab vs Ezetimibe in Patients With Muscle-Related Statin Intolerance
- (2016) Steven E. Nissen et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- The nocebo effect in the context of statin intolerance
- (2016) Jonathan A. Tobert et al. Journal of Clinical Lipidology
- Liver-specific ATP-citrate lyase inhibition by bempedoic acid decreases LDL-C and attenuates atherosclerosis
- (2016) Stephen L. Pinkosky et al. Nature Communications
- Statin-associated muscle symptoms EAS Consensus Panel paper focuses on this neglected patient group
- (2015) Jane Stock ATHEROSCLEROSIS
- A Century of Cholesterol and Coronaries: From Plaques to Genes to Statins
- (2015) Joseph L. Goldstein et al. CELL
- Statin-associated muscle symptoms: impact on statin therapy—European Atherosclerosis Society Consensus Panel Statement on Assessment, Aetiology and Management
- (2015) Erik S. Stroes et al. EUROPEAN HEART JOURNAL
- Efficacy and safety of alirocumab vs ezetimibe in statin-intolerant patients, with a statin rechallenge arm: The ODYSSEY ALTERNATIVE randomized trial
- (2015) Patrick M. Moriarty et al. Journal of Clinical Lipidology
- Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes
- (2015) Christopher P. Cannon et al. NEW ENGLAND JOURNAL OF MEDICINE
- A systematic review of statin-induced muscle problems in clinical trials
- (2014) Harsha V. Ganga et al. AMERICAN HEART JOURNAL
- An assessment by the Statin Muscle Safety Task Force: 2014 update
- (2014) Robert S. Rosenson et al. Journal of Clinical Lipidology
- An assessment by the Statin Liver Safety Task Force: 2014 update
- (2014) Harold Bays et al. Journal of Clinical Lipidology
- A clinician's guide to statin drug-drug interactions
- (2014) Kenneth A. Kellick et al. Journal of Clinical Lipidology
- Meta-Analysis of Impact of Different Types and Doses of Statins on New-Onset Diabetes Mellitus
- (2013) Eliano Pio Navarese et al. AMERICAN JOURNAL OF CARDIOLOGY
- Intermittent Nondaily Dosing Strategies in Patients with Previous Statin-Induced Myopathy
- (2013) Alyssa J Keating et al. ANNALS OF PHARMACOTHERAPY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation